Global Cancer Immunotherapy Market
According to the report " Cancer Immunotherapy Market ", published by Market Data Forecast , the global market is projected to reach USD 111.23 Billion by 2021 , at a CAGR of 12.40 % from 2016 to 2021 .
Cancer immunotherapy helps in inhibiting the growth of the cancer cells , stopping the cancer cells from spreading across the body , helping the immune system to fight better against the cancer cells . However , high effectiveness of treatment by cancer immunotherapy and less side effects associated with the treatments witness lucrative growth during the forecast period .
The Key drivers of the market are increasing occurrence of cancer , Smoking and excessive alcoholic intake , Changing life style , high efficacy of immunotherapy compared to other treatments , less side effects associated with cancer immunotherapy , reduced chance of recurrence of cancer . Cost of cancer therapies , limited information on cancer immunobiology and various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies are the major restraints that hamper the growth of the Cancer immunotherapy market .
Global Cancer Immunotherapy Market is segmented based on Application , Product Type , Mode of Administration , End users and Region .
1 . Based on Application :
� � � � � � �
Breast Lung Melanoma Colorectal Head & Neck Prostate others
2 . Based on Product Type :
� �
Monoclonal Antibodies Checkpoint inhibitors / immune modulators
+ 1 888-702-9626 | www . marketdataforecast . com | contact @ marketdataforecast . com